Documentos relacionados

1. Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index.
2. Optimal peritoneal cancer index cutoff point for predicting surgical resectability of pseudomyxoma peritonei in treatment-naive patients.
3. Rationale of Treatment for Peritoneal Metastasis.
4. [Clinical evaluation of tumor-stroma ratio in pseudomyxoma peritonei from the appendix].
5. Long-term survival in patients with PMP: a single-institutional retrospective study from China.
6. Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant Pathology.
7. Nomogram to Predict Incomplete Cytoreduction for Pseudomyxoma Peritonei.
8. From the Ronnett to the PSOGI Classification System for Pseudomyxoma Peritonei: A Validation Study.
9. Etiological analysis of infection after CRS + HIPEC in patients with PMP.
10. Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept.